IGFBP7-AS1 is reported to be significantly associated with overall survival in patients with glioblastoma, and IGFBP7-AS1 knockdown inhibited the function of glioma cells in viability, migration, and invasion [18]. Here, IGFBP7 is linked to central nervous system cancer.